Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ALLOCompany Name
ALLOGENE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALLOGENE THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALLO - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -223.22M | 0% | $ 0 |
| 3/31/2025 | $ -238.37M | 0% | $ 0 |
| 12/31/2024 | $ -243.33M | -1106031.82% | $ 22K |
| 9/30/2024 | $ -272.93M | 0% | $ -22K |
| 6/30/2024 | $ -267.68M | -1274676.19% | $ 21K |
| 3/31/2024 | $ -279.31M | -429713.85% | $ 65K |
| 12/31/2023 | $ -313.07M | -329543.16% | $ 95K |
| 9/30/2023 | $ -319.06M | -171540.32% | $ 186K |
| 6/30/2023 | $ -340.61M | -177401.04% | $ 192K |
| 3/31/2023 | $ -337.38M | -144177.78% | $ 234K |
Key Performance Insights, Last 5 Years
- ALLOGENE THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, ALLOGENE THERAPEUTICS INC's average EBITDA % has been -276535.55%.
- The median EBITDA % for ALLOGENE THERAPEUTICS INC during this period was -142249.76%
- ALLOGENE THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -577.12%.
- The lowest EBITDA % recorded by ALLOGENE THERAPEUTICS INC in the same timeframe -1274676.19%
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ALLOGENE THERAPEUTICS INC is calculated as follows: EBITDA [ $ -235.54M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] ALLO - EBITDA Margin, Last 5 years
-1274676.19%
Minimum
Jun 30, 2024
-577.12%
Maximum
Mar 31, 2021
-276535.55%
Average
-142249.76%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |